No abstract available
MeSH terms
-
Amyloid / metabolism*
-
Antineoplastic Agents / administration & dosage
-
Bortezomib / administration & dosage*
-
Cardiomyopathies* / blood
-
Cardiomyopathies* / diagnosis
-
Cardiomyopathies* / etiology
-
Cyclophosphamide / administration & dosage*
-
Dexamethasone / administration & dosage*
-
Fatigue / diagnosis
-
Fatigue / etiology
-
Hepatomegaly* / diagnostic imaging
-
Hepatomegaly* / etiology
-
Humans
-
Image-Guided Biopsy / methods
-
Immunoglobulin Light-chain Amyloidosis* / diagnosis
-
Immunoglobulin Light-chain Amyloidosis* / metabolism
-
Immunoglobulin Light-chain Amyloidosis* / physiopathology
-
Immunohistochemistry
-
Male
-
Middle Aged
-
Natriuretic Peptide, Brain / blood
-
Peptide Fragments / blood
-
Peritoneal Neoplasms / diagnosis
-
Peritoneal Neoplasms / pathology
-
Splenomegaly* / diagnostic imaging
-
Splenomegaly* / etiology
-
Tomography, X-Ray Computed / methods
-
Treatment Outcome
-
Weight Loss
Substances
-
Amyloid
-
Antineoplastic Agents
-
Peptide Fragments
-
amyloid protein AL
-
pro-brain natriuretic peptide (1-76)
-
Natriuretic Peptide, Brain
-
Bortezomib
-
Dexamethasone
-
Cyclophosphamide